Target intelligence / Profile preview

Ras-related protein Rab-38 (RAB38)

Target
RAB38
Molecular classification
Small GTPase, Rab family (Ras superfamily), Vesicular trafficking regulator, Other (not a receptor, enzyme, ion channel, etc.)
01

Overview

Ras-related protein Rab-38 (RAB38) is a member of the Rab subfamily of small GTPases and plays a critical role in vesicle-mediated trafficking, particularly from endosomes to melanosomes and in the assembly of melanosomes—specialized organelles involved in pigment production. RAB38 is predominantly expressed in melanocytes and retinal pigment epithelial cells, where it controls the sorting and transport of enzymes such as tyrosinase-related protein 1 (TYRP1) into melanosomes. Deficiency or mutations in RAB38 disrupt melanosome targeting of these enzymes, resulting in pigmentation disorders such as oculocutaneous albinism and in mouse models, altered coat color ("chocolate" phenotype). RAB38 also contributes to phagosome acidification and maturation, impacting immune response to pathogens. It acts as a GTP-dependent molecular switch to recruit effectors for vesicle formation, tethering, and fusion in subcellular compartments. RAB38 is not currently a direct therapeutic target for approved drugs, but its molecular roles in cell trafficking and disease associations make it important in research on pigmentation, lysosome-related organelles, and vesicular transport.

Other names
RAB38NY-MEL-1Melanoma antigen NY-MEL-1rrGTPbpRab-related GTP-binding protein
02

Mechanism of action

Not applicable (no drugs documented, but theoretically, small molecule inhibitors or biotechnological approaches could affect GTP binding/hydrolysis or vesicle trafficking for research purposes.)

03

Biological functions

Intracellular vesicle traffickingEndosome to melanosome transportMelanosome assembly and biogenesisPhagosome maturationRegulation of pigmentation (melanin production)
04

Disease associations

Oculocutaneous albinismCarpenter syndrome 1Pigmentation disordersOther (mutations affect melanosome-targeted diseases and may have broader cell trafficking implications)
05

Safety considerations

Notable animal models indicate loss-of-function mutations can lead to pigmentation defects, including incomplete melanosome assembly or abnormal trafficking of melanogenic enzymes (suggesting potential off-target risks for therapies modulating vesicular trafficking).
06

Biomarkers

Pigmentation phenotype (e.g., coat color in mice; human pigmentation variation)Levels/localization of tyrosinase and TYRP1 in melanosomes

Beyond the preview

Go deeper on Ras-related protein Rab-38 (RAB38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-38 (RAB38).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call